July 11th 2025
New research finds that nearly half of the racial and ethnic disparities in outpatient COVID-19 antiviral prescriptions stem from encounter-level care barriers, such as limited access to rapid tests and telehealth, which emphasizes the need for systemic and practice-level reforms.
PAP 2024: John Hoffman Discusses the Inflation Reduction Act and Current Advocacy Efforts
March 21st 2024In an interview with Pharma Commerce Associate Editor Don Tracy, John Hoffman, Principal, Advocate for Success, LLC offers his thoughts on the Inflation Reduction Act and discusses current advocacy efforts.
PAP 2024: Michael Galarraga Discusses "The State of Patient Access and Affordability”
March 20th 2024In an interview with Pharma Commerce Associate Editor Don Tracy, Michael Galarraga, LPC, ATR-BC, Pennsylvania State Representative, OutCare Health offers his thoughts on the breakout session and his experience in mental health counseling.
Examining the Impact of the COVID-19 Pandemic on Patient Portal Use
March 1st 2024A JAMA Network Open study dives into how the utilization of a digital patient portal changed during the COVID-19 pandemic, while also exploring ways that multimorbidity and socioeconomic disparities affected those statistics.
Cencora's Corey Ford Discusses the Future of the Inflation Reduction Act
February 29th 2024In an interview with Pharma Commerce Associate Editor Don Tracy, Corey Ford, VP, Reimbursement & Policy Insights, Cencora, offers his thoughts on where the Inflation Reduction Act will be five to 10 years from now.
Cencora VP of Reimbursement & Policy Insights Discusses Implications of the Inflation Reduction Act
February 28th 2024In an interview with Pharma Commerce Associate Editor Don Tracy, Corey Ford, VP, Reimbursement, Policy Insights, Cencora, provides a look at his recent webinar focused on the implications of the Inflation Reduction Act.